senior immunologist
Infectious Disease
Division of Virology United States Army Medical Research Institute of Infectious Diseases,
Belgium
As the senior immunologist for the Ebola and pre-erythrocytic malaria vaccine trials, I oversee the immunology on Phase I and II trials of vectored vaccines, both in the UK and in field trials in Africa. We use the chimpanzee adenovirus, ChAd63, as a priming vector and modified vaccinia virus (MVA) as a boosting vaccination and these viruses encode proteins from the organism that can elicit protective immune responses in our vaccinated volunteers. As the senior immunologist for the Ebola and pre-erythrocytic malaria vaccine trials, I oversee the immunology on Phase I and II trials of vectored vaccines, both in the UK and in field trials in Africa. We use the chimpanzee adenovirus, ChAd63, as a priming vector and modified vaccinia virus (MVA) as a boosting vaccination and these viruses encode proteins from the organism that can elicit protective immune responses in our vaccinated volunteers.
vaccine-induced immunological parameters that correlate with protection from malaria